The current earnings forecast score of Treace Medical Concepts Inc is 6.00, ranking 172 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 5.00, with a high of 7.50 and a low of 4.00.
Analyst Rating
Based on
5
analysts
Hold
Current Rating
4.667
Target Price
+8.28%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Treace Medical Concepts Inc
TMCI
5
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Treace Medical Concepts Inc's expected revenue for the next quarter?
Treace Medical Concepts Inc's expected revenue is 44.02M.
What is Treace Medical Concepts Inc's price target?
Analysts forecast that Treace Medical Concepts Inc's price target is USD 5.00, with the highest forecast at USD 7.50 and the lowest forecast at USD 4.00.
How have Treace Medical Concepts IncTMCI's recent earnings per share performed?
The market expectation was USD -0.28, while Treace Medical Concepts IncTMCI's earnings per share (EPS) for the previous quarter was USD -0.15. EPS for the next quarter is expected at USD -0.30.
What is the analyst rating for Treace Medical Concepts Inc?
Based on the ratings of Treace Medical Concepts Inc's stock from 5 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.